The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ezetimibe/Simvastatin Teva Pharma 10 mg/20 mg tablets

Teva B.V.PA1986/067/001

Main Information

Trade NameEzetimibe/Simvastatin Teva Pharma 10 mg/20 mg tablets
Active SubstancesEzetimibe
Dosage FormTablet
Licence HolderTeva B.V.
Licence NumberPA1986/067/001

Group Information

ATC CodeH01CB Somatostatin and analogues
H01CB02 octreotide


License statusAuthorised
Licence Issued16/12/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0034-051-002
Interchangeable List DocumentPDF of Interchangeable List
« Back